Le Lézard
Classified in: Health
Subjects: NPT, VET, MAT

The Veterans Cannabis Group Joins Forces with Metta Medical to Co-Sponsor a New Scientific Study Into the Effectiveness of Cannabis on Sleep


SAN FRANCISCO, Nov. 11, 2021 /PRNewswire-PRWeb/ -- The Veterans Cannabis Group (VCG), a national non-profit advocacy organization founded in 2016, announced today, in honor of Veteran's Day, its official partnership with Metta Medical, maker of LEVEL brand cannabis edible products, to co-sponsor ECS21, a California-based study into cannabinoid cannabigerol's potential for improving sleep.

The ECS21 study will track the effects of cannabigerol - known as CBG - on the sleep patterns of over 100 Veteran volunteers for an eight-week period. By using Fitbit smartwatches and an app created by Curebase, a company committed to democratizing access to clinical studies that is also a partner in ECS21, the decentralized clinical trial leverages technology to reach a broader range of volunteer participants. Because it is able to include a more diverse range of veterans - like those who live outside major cities or lack dependable transportation - the study's results - which are due out in 2022 - will provide deep insight into the potential medicinal uses for CBG to improve one's sleep.

"In 2019, the VA reported the veteran suicide rate to be 52.3% higher than the general population," said VCG Founder and former Army Sergeant, Aaron Augustis. "With sleep disorders greatly impacting one's overall wellbeing, it's obvious that helping veterans - and everyone - get better sleep is a key solution to the battle to end the veteran suicide crisis."

Similar to the VCG, Metta Medical's mission is to destigmatize cannabis use and encourage additional research into the plant's possible medicinal benefits.

"As a former US Navy veteran, I deeply empathize with those who carry the scars of war," adds Metta Medical Founder, Chris Emerson. "I can see no better use for scientific study than to advance our understanding of how to use this natural plant to make effective, safe medicines."

The Veterans Cannabis Group's policy work has long focused on improving both state and federal-level governmental understanding and acceptance of cannabis's medicinal uses. In 2017, for example, VCG Founder Aaron Augustis visited Capitol Hill to speak on cannabis's potential uses upon invitation from Washington D.C. leadership, including representatives from the Department of Veteran's Affairs. More recently, beginning in 2019, the VCG provided veteran-level support to help successfully pass 2020's California Senate Bill 34, an initiative designed to ease access to medicinal cannabis for those in need.

Air Force Veteran and VCG Co-founder and Board Member, Jeremy Freitas concludes, "The ECS21 study represents the Veterans Cannabis Group's ever-present commitment to driving forward the global medicinal cannabis movement by adding to a shared body of scientific knowledge into the many curative possibilities cannabis offers while also serving the men and women who so bravely served our nation."

To learn more about the Veterans Cannabis Group and the services they provide veterans and their families, visit http://www.veteranscannabisgroup.com.

ABOUT VETERANS CANNABIS GROUP

As a veteran-led advocacy group supporting veterans who use medicinal cannabis to alleviate their service-connected disabilities, the Veterans Cannabis Group is mission-driven to strengthen relationships between veteran communities, the cannabis industry, scientists, healthcare professionals, and city, state and Federal governments. Founded in 2016 in California by former US Army Sergeant Aaron Augustis, the group provides veterans and their families education about and safe access to medicinal cannabis alongside career opportunities and information on official US Department of Veterans Affairs benefits. By working directly with the VA in support of safe access to and continued scientific study of medicinal cannabis, the Veterans Cannabis Group advances the global cannabis medicinal movement. For more information, visit https://veteranscannabisgroup.com.

ABOUT LEVEL

LEVEL is a cannabinoid research and development company that is unlocking the true potential of cannabis to deliver brand-new highs with targeted effects. LEVEL formulates with cannabinoids you don't often hear about (CBG, CBN, THCa, THCv, Delta-8 THC) as well as the ones you do (Delta-9 THC and CBD) into swallowable and dissolvable tablets. LEVEL's products are scientifically designed to deliver the desired effect, every time. Whether you're looking to focus on a project, get a good night's sleep, prevent a hangover, relieve stress, or soothe aches and pains, there's a unique cannabinoid profile for that. We crafted the range of doses and intake methods we offer with the intention of providing tools that help you discover what your body responds to best?no matter your experience level with cannabis. For more information, visit https://levelexperience.com/.

Media Contact

Lee Anna Mariglia, Veterans Cannabis Group, 1 415.786.1832, [email protected]

 

SOURCE Veterans Cannabis Group


These press releases may also interest you

at 13:50
Merck , known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.69 per share of the company's common stock for the third quarter of 2022. Payment will be made on July 8,...

at 13:25
ICP DAS - BMP (Biomedical Polymers), a Taiwanese medical TPU (thermoplastic polyurethane) supplier, will exhibit at Medical Taiwan 2022, an international medical, health, and care expo. The Medical Taiwan Expo 2022 will take place at the Taipei...

at 13:24
VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that it has...

at 13:20
Magnolia Medical Technologies, Inc., ("Magnolia") inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®), today announced that it has received a formal close-out notification from the United States Food and Drug Administration ("FDA")...

at 13:00
ICS Medical Devices, a leading catheter design & manufacturing services provider, today announced a significant expansion of its operations in Galway, Ireland. The company is moving into a new 16,000- square-foot manufacturing facility, more than...

at 13:00
GEMCORE, a leading provider of diabetes management solutions, today announced that its operational platforms - Microsoft Dynamics GP, Microsoft Office 365, Microsoft D365, Brightree, ProShip, Vertex, and PioneerRx - have earned Certified status for...



News published on 11 november 2021 at 14:10 and distributed by: